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In the central nervous system, ﬁbroblast growth factor (FGF)-20 has been reported to act preferentially on midbrain dopaminergic
neurons. It also promotes the dopaminergic differentiation of stem cells. We have analyzed the effects of FGF-20 on human embryonic
stem cells (hESCs) differentiation into dopaminergic neurons. We induced neuronal differentiation of hESCs by co-culturing those with
PA6 mouse stromal cells for 3 weeks. When we supplemented the culture medium with FGF-20, the number of tyrosine hydroxylase (TH)-
expressing neurons increased ﬁvefold, from 3% to 15% of the hESC-derived cells. The cultured cells also expressed other midbrain
dopaminergic markers (PITX3, En1, Msx1, and Aldh1), suggesting that some had differentiated into midbrain dopaminergic neurons. We
observed no effect of FGF-20 on the size of the soma area or neurite length of the TH-immunopositive neurons. Regardless of whether
FGF-20 had been added or not, 17% of the hESC-derived cells expressed the pan-neuronal marker b-III-Tubulin. The proportion of
proliferating cells positive for Ki-67 was also not affected by FGF-20 (7% of the hESC-derived cells). By contrast, after 3 weeks in culture
FGF-20 signiﬁcantly reduced the proportion of cells undergoing cell death, as revealed by immunoreactivity for cleaved caspase-8, Bcl-2
associated X protein (BAX) and cleaved caspase-3 (2.5% to 1.2% of cleaved caspase-3-positive cells out of the hESC-derived cells).
Taken together, our results indicate that FGF-20 speciﬁcally increases the yield of dopaminergic neurons from hESCs grown on PA6
feeder cells and at least part of this effect is due to a reduction in cell death.
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INTRODUCTION
Parkinson’s disease is a progressive neurodegenerative disorder, charac-
terizedbytremor,musclerigidity,andbradykinesia,whichprimarilyisdue
to the degeneration of dopaminergic neurons in the substantia nigra
(Braak et al., 2004). Replacement of the lost dopaminergic neurons by
transplantation has been tested, with varying degrees of success, as a
therapy for Parkinson’s disease (Bjorklund et al., 2003). These trials have
used ventral mesencephalic donor tissue obtained from routine abortions.
However, the usage of this source of donor tissue is associated with
several problems. For example, it is not readily obtainable; its develop-
mental stage varies; it is heterogeneous in cell composition; it differs in
quality due to different post-mortem delays and handling procedures; and
it is inherently connected to ethical issues related to the abortion
(Freeman, 2006). An ideal source of cell material should be obtainable
in large quantities in a predictable manner, highly enriched in midbrain
dopaminergic neurons of a substantia nigra phenotype, and safe to
transplant with no risks of infection or tumor growth (Takahashi, 2007).
Embryonic stem cells (ESCs), derived from the inner cell mass of human
blastocysts, are such a potential source of cells. They are pluripotent,
can self-renew and it is possible to derive dopaminergic neurons from
humanESCs(hESCs)byusingvariouscellcultureprotocols.Speciﬁctypes
of feeder cells and combinations of signaling molecules have been shown
to induce the differentiation of hESCs into dopaminergic neurons (Ben-Hur
et al., 2004; Iacovitti et al., 2007; Perrier et al., 2004; Roy et al., 2006;
Schulz et al., 2004; Zeng et al., 2004). So far, the highest proportion of
neurons expressing the dopamine-synthesizing enzyme tyrosine hydro-
xylase (TH) obtained from hESCs is 65–78% (Perrier et al., 2004).
Wewereinterestedinstudyingtheeffectsofagrowthfactorpreviously
not tested in this context, on its ability to further promote the number of
dopaminergic neurons obtained from hESCs. Fibroblast growth factor
(FGF)-20 and its receptor are expressed in the substantia nigra and FGF-
20 has a preferential neurotrophic activity, including a survival-promoting
effect, on dopaminergic neurons (Murase and McKay, 2006; Ohmachi
et al., 2000; Ohmachi et al., 2003). This factor also promotes the
differentiation of certain types of stem cells into dopaminergic neurons in
vitro (Grothe et al., 2004; Takagi et al., 2005). Based on these properties of
FGF-20, we hypothesized that FGF-20 would increase the yield of
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10.3389/neuro.05.004.2007dopaminergic neurons derived from hESCs. We supplemented cultures of
hESCs, during differentiation on PA6 stromal feeder cells (Kawasaki et al.,
2000), with FGF-20. We report that FGF-20 supports a ﬁvefold increase in
the percentage of hESC-derived TH-expressing neurons and reduces cell
death during differentiation. Our study provides novel information of
importance to cell-replacement therapy for Parkinson’s disease based on
dopaminergic neurons derived from hESCs.
MATERIALS AND METHODS
SDIA method for in vitro differentiation of hESCs into DA neurons
We maintained undifferentiated hESCs (SA002 cell line, Cellartis,
Go ¨teborg, Sweden) on irradiated human foreskin ﬁbroblasts (hFFs,
CRL-2429, ATCC,Manassas, VA; feeder celldensity 36,000–45,000 cells/
cm
2) using medium containing serum replacement (VitroHES medium,
Vitrolife Sweden AB, Sweden), supplemented with 4ng/ml of basic
ﬁbroblast growth factor (human recombinant bFGF, also known as FGF-2,
Invitrogen, CA). Every 6–7 days, we cut hESC colonies into small cell
clusters, and used glass stem cell knives (SweMed AB, Sweden) to
mechanically separate them from hFFs. We then placed the clusters of
hESCs on top of fresh hFFs for expansion, or on top of PA6 mouse bone
marrow stromal cell feeders for differentiation. Details regarding the
protocol for culturing PA6 cells have been described previously (Kawasaki
et al., 2000). For immunocytochemical analysis of differentiated cells, we
plated PA6 cells on collagen-coated glass coverslips in 4-well-plates at
the density of 20,000–25,000 cells/cm
2 2 days prior to co-culturing with
hESCs. For RT-PCR analysis, we co-cultured hESCs and PA6 cells on
gelatine-coated plastic 35mm Petri dishes. Before starting the hESC/PA6
co-cultures, we rinsed the PA6 cell three times with phosphate buffered
saline (PBS) to remove the traces of serum-containing PA6 culture
medium. We maintained the co-cultures in medium composed of
Glasgow’s modiﬁed Eagle’s medium (G-MEM) supplemented with 8%
knockout serum replacement (KO-SR), 2mM L-glutamine, 0.1mM non-
essential amino acids (NEAA), 1mM pyruvate, 0.1mM 2-mercaptoethanol
(2-ME), and 4ng/ml bFGF (all from Invitrogen). In hESC differentiation
studies, FGF-20 (PeproTech EC, UK) was added in a concentration of
1ng/ml.Basedontheresultsofpilotexperimentsinwhichwetestedthree
concentrations of FGF-20 (100pg/ml, 1ng/ml, and 10ng/ml), we chose to
treat our cultures with 1ng/ml FGF-20. For ﬁrst 10 days of co-culturing,
we changed one half of the medium volume every other day, followed by
daily changes until a total of 21 days.
Immunocytochemistry
Following 3 weeks of culturing, we ﬁxed the hESC/PA6 co-cultures with
4% paraformaldehyde (PFA) for 30 minutes. We pre-incubated the ﬁxed
cells in blocking solution containing PBS, 0.5% Triton X-100, and 10% of
normal serum from the same animal species as the secondary antibody.
We then incubated cultures with primary antibodies in blocking solution
overnight at room temperature. Following three washes with PBS, we
incubated cells with donkey anti-mouse IgG conjugated with FITC, Cy2, or
Cy3 (1:200, Jackson ImmunoResearch Europe Ltd., UK). Subsequently,
we washed cells with PBS and incubated them with 1:1000 40,6-
diamidino-2-phenylindole (DAPI) in PBS for 10 minutes. Using PVA
mounting medium containing anti-fading reagent DABCO we mounted the
glass coverslips onto glass slides. The primary antibodies that we used
were the following: mouse monoclonal anti-human nuclei (HNuc, 1:200);
rabbit polyclonal anti-TH (1:500); rabbit polyclonal anti-vesicular
monoamine transporter (VMAT)-2 (1:500, all from Chemicon, CA); mouse
monoclonal anti-Nestin (1:50); goat polyclonal anti-PITX3 (1:50, both from
Santa Cruz Biotechnology, Inc., CA); rabbit polyclonal anti-b-III-Tubulin
(1:500, Nordic BioSite AB, Sweden); rabbit monoclonal anti-cleaved
caspase-3 (1:100); rabbit polyclonal cleaved caspase-8 (1:100), rabbit
polyclonal Bcl-2 associated X protein (BAX, 1:100, all from Cell Signalling
Technology, MA); rabbit polyclonal anti-Ki67 (1:200, Novocastra
Laboratories, UK); mouse monoclonal anti-FGF receptor 1 (FGFR-1,
1:80, Zymed Laboratories Inc., CA).
Cell counting, neurite outgrowth estimation, soma area
measurements, and statistical analysis
We quantiﬁed the percentages of TH-, b-III-Tubulin-, Ki67-, and cleaved
caspase-3-positive cells from four independent experiments. We applied
stereological principles to assess cell numbers using the Visiopharm
Integrator System version 2.12.1.0 software. After delineating the culture
areas covered with HNuc-positive cells, we assessed the numbers of
immunopositive cells using a systematic random sampling technique. We
analyzed about 1000 cells in each culture. Using the StatView 5.0
software we performed the statistical evaluation by student’s t-test for
two unpaired groups. Cell fraction data were presented as means SEM.
We estimated the neurite length per cell by counting the number of
intersections of neuritis and six probe lines equally spaced in the counting
frame drawn by the Visiopharm Integrator System program. We analyzed
at least 100 neurons per culture of three independent experiments
(totaling 300 cells per culture condition) and presented the data as
means SD. This method is an adaptation of the procedure developed by
Ronn et al., (2000). For the estimation of soma area we randomly chose
20cellspercultureofthreeindependentexperiments(totaling80cellsper
culture condition) and measured the soma area of each cells again using
the Visiopharm Integrator System program. Soma area data were
presented as means SD.
RNA puriﬁcation and cDNA synthesis
For RNA puriﬁcation of undifferentiated hESCs, we mechanically
separated the hESCs from hFFs, collected the former in a 500ml volume
of VitroHES media, rinsed in PBS buffer and spun down at 300 rcf for
5minutes. To harvest hESC-derived cells grown atop PA6 cells (in the
presence or absence of FGF-20) we used the papain dissociation kit
(Worthington Biochemical Corporation, NJ), rinsed cells in PBS buffer and
spun down as described above. We then resuspended the resulting cell
pellets in RLT buffer (QIAGEN, UK), passed through the shredder column
(QIAGEN)andstoredat 808CuntiltheRNAsamplewaspuriﬁedfollowing
theRNeasyMicro Kit(QIAGEN)protocol (withoutcarrier RNA);withDNaseI
(QIAGEN) treatment incorporated to the latter. Using a ND-1000
specrophotometer (NanoDrop, USA) we tested the RNA integrity. Later
we synthesized cDNA from 400ng of total RNA using SuperScript II
(Invitrogen), essentially as recommended by the manufacturer, with
extended synthesis step (50minutes).
RT-PCR
We selected the primers for RT-PCR from published works (Hori et al.,
2005; Jorgensen et al., 2006; Kukekov et al., 1999; Yu et al., 2006)o r
designed those using Oligo 4.0 software (Molecular Biology Insight) or
Clone Manager Suite 7.1 (Sci Ed Software, NC), as appear at Table 1.W e
ordered all primers from TAG Copenhagen A/S, Denmark. Using the
MiniOpticon system (Bio-Rad, USA) with REDTaq Polymerase (Sigma-
Aldrich, Germany) we performed the RT-PCR ampliﬁcations, essentially as
described by the manufacturer. Following initial denaturation for
5minutes at 958C, we performed DNA ampliﬁcations for 32 (Aldh1a1),
33 (Hprt, Th, Msx1) or 35 (En1) cycles of 1minutes at 958C, 1minutes at
558C (En1), 58.58C (Th) or 598C (Aldh1a1, Hprt, Msx1), and 1minutes at
728C. The ﬁnal extension was 5minutes at 728C. We analyzed 20ml
volumes of RT-PCR products by electrophoresis at 1% Agarose gels and
visualized by Ethidium Bromide staining.
RESULTS
FGF-20 promotes the differentiation of hESCs into midbrain
dopaminergic neurons
We maintained the hESC colonies on hFFs (Figure 1A). In order to induce
the differentiation of hESCs into dopaminergic neurons, we isolated
Correia et al.
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PA6 mouse stromal cells (Figure 1B). We conﬁrmed the neuronal
differentiation ofthehESCsbytheexpressionoftheearlyneuronal marker
Nestin in a large proportion of the cells (Figures 1C–1F). This observation
is in good agreement with the known capacity of PA6 cells to induce
neuronal differentiation in ESCs (Brederlau et al., 2006; Kawasaki et al.,
2000; Morizane et al., 2002; Takagi et al., 2005).
Theactivity of FGF-20 is mediatedby the FGFR-1 (Ohmachi et al., 2003).
We detected this receptor on undifferentiated hESCs (Figures 1G–1I), PA6
cells (Figures 1J–1L), and hESC-derived TH-positive neurons (Figures
1M–1O). Therefore FGF-20 might act directly on hESCs and on
differentiated TH-expressing neurons. FGF-20 might also stimulate the
PA6 cells to release factors that promote the dopaminergic differentiation
and the survival of the derived dopaminergic neurons.
In addition to having a neurotrophic activity on rat midbrain
dopaminergic neurons (Ohmachi et al., 2000), FGF-20 also increases
the numbers of TH-expressing neurons derived from stem cells in vitro
(Grothe et al., 2004; Takagi et al., 2005). When we treated hESC/PA6 co-
cultures with FGF-20 we observed a ﬁvefold increase in the yield of TH-
positivecells(Figures2A–2C).ThepercentageofTH-positive neuronsout
of HNuc-positive cells was 3 1% in the absence of FGF-20 ( FGF-20),
while it increased to 15 2% in the presence of FGF-20 (þFGF-20)
(Figure 2C). The TH-positive neurons co-expressed the vesicular
monoamine transporter (VMAT)-2 (Figures 2D and 2E), which is involved
in the vesicular transport of dopamine (Nirenberg et al., 1996). The hESC-
derived TH-positive neurons also co-expressed the paired-like home-
odomaintranscriptionfactor3(PITX3,Figures2Fand2G),requiredforthe
development of substantia nigra dopaminergic neurons (Nunes et al.,
2003). We detected the homeobox transciption factor engrailed 1 (En1),
which is essential for the maintenance of substantia nigra dopaminergic
neurons (Alberi et al., 2004), by RT-PCR (Figure 2H). Using RT-PCR, we
also detected expression of the homeobox transcription factor msh-like 1
(Msx1) (Andersson et al., 2006) and the enzyme aldehyde dehydrogenase
1 (Aldh1) (Galter et al., 2003), which are also involved in the development
of midbrain dopaminergic neurons (Figure 2H). Furthermore, we found
lower expression levels of two markers of undifferentiated and pluripotent
cells, that is, Oct3/4 and Nanog, in differentiated hESC/PA6 co-cultures
supplemented with FGF-20 than in cultures untreated with FGF-20,
indicating the effect of this factor in promoting differentiation (Figure 2H).
Other neurotrophic factors, such as glial cell line-derived neurotrophic
factor (GDNF), neurotrophins (NTs), and transforming growth factor
(TGF)-a are known to increase the neurite length and soma area of
mesencephalic neurons in culture (Alexi and Hefti, 1993; Studer et al.,
1995; Studer et al., 1996; Widmer et al., 2000). We evaluated the effect of
FGF-20 on neurite outgrowth of hESC-derived TH-positive neurons by
quantifying the number of intersections between the neurites of each cell
with six probe lines, equally spaced and drawn on the counting frame, as
described by Ronn et al., (2000). We observed no increase in neurite
length in cultures treated with FGF-20 (Figure 2I). Similarly, we observed
no effect of FGF-20 treatment in the soma area of hESC-derived TH-
positive neurons (Figure 2J). These results suggest that FGF-20 has no
signiﬁcant effect on hESC-derived TH-positive neuron morphology.
FGF-20 has no effect in the neuronal differentiation of hESCs
The neurotrophic activity of FGF-20 is considered to be speciﬁc for TH-
expressing neurons in primary cultures of rat mesencephalic neurons
(Ohmachi et al., 2003). FGF-20 increases the survival of TH-expressing
neurons in serum-free medium, but it does not support a general survival-
promoting effect on all other neurons (Ohmachi et al., 2003). In our hESC/
PA6 co-cultures, FGF-20 did not increase the fraction of hESC-derived
cells expressing the neuronal marker b-III-Tubulin (Figures 3A and 3B).
The percentage of the HNuc-positive cells that expressed b-III-Tubulin
was 18 1% and 16 2% in the FGF-20 treated and untreated cultures,
respectively (Figure 3C). As expected, all the TH-positive neurons co-
express b-III-Tubulin (Figures 3D and 3E). Therefore, we can speculate
that the percentage of b-III-Tubulin-positive cells co-expressing TH was
about 85% in FGF-20-supplemented cultures, and 19% in the cultures
lacking FGF-20 (N¼4). Taken together, these data suggest that FGF-20
may promote speciﬁcally the differentiation of hESCs into dopaminergic
neurons, but not general neuronal differentiation.
FGF-20 signiﬁcantly reduces cell death through apoptosis
but has no effect on cell proliferation
Anti-apoptotic mechanisms have been shown to be activated by FGF-20
on dopaminergic neurons (Murase and McKay, 2006). We examined
whether FGF-20 reduced apoptotic cell death in hESC/PA6 co-cultures.
We identiﬁed dying cells by the presence of cleaved caspase-8, cleaved
caspase-3,andoligomerizedBAX(Figures4A–4F).Activationofcaspase-
8 into cleaved active fragments is induced by signaling through the FasL/
Fas receptor, as part of the extrinsic cell death pathway. It triggers the
activation of a cascade of downstream caspases (Riedl and Shi, 2004).
Table 1. List of primers used in this study.
Gene name Abbreviation Primers Orientation Product size (bp)
Tubulin beta Tubb 50-CTCACAAGTACGTGCCTCGAG-30 Sense 593
50-GCACGACGCTGAAGGTGTTCA-30 Anti-sense
Hypoxanthine guanine phosphoribosyltransferase 1 Hprt 50-TGTAATGACCAGTCAACAGGG-30 Sense 816
50-TGGCTTATATCCAACACTTCG-30 Anti-sense
Glyceraldehyde-3-phosphate dehydrogenase Gapdh 50-TTAGCACCCCTGGCCAAGG-30 Sense 452
50-CTTACTCCTTGGAGGCCATG-30 Anti-sense
Octamer-binding transcription factor 3/4 Oct3/4 50-CTTGCTGCAGAAGTGGGTGGAGGA-30 Sense 360
50-CTGCAGTGTGGGTTTCGGGCA-30 Anti-sense
Homeobox transcription factor Nanog Nanog 50-TGCTTATTCAGGACAGCCT-30 Sense 538
50-TCTGGTCTTCTGTTTCTTGACT-30 Anti-sense
Aldehyde dehydrogenase 1 family, member A1 Aldh1 50-GGGCAGCCATTTCTTCTCAC-30 Sense 1181
50-CTTCTTAGCCCGCTCAACAC-30 Anti-sense
Homeobox transcription factor msx-like 1 Msx1 50-CGAGCTGTGAAGGTGTTTG-30 Sense 332
50-TTGGTGACCAGGTGATGAC-30 Anti-sense
Tyrosine hydroxylase Th 50-CGAGCTGTGAAGGTGTTTG-30 Sense 245
50-TTGGTGACCAGGTGATGAC-30 Anti-sense
Engrailed 1 En1 50-AAGGGACGAAACTGCGAACTCC-30 Sense 245
50-GACACGAAAGGAAACACACACTCTCG-30 Anti-sense
FGF-20 promotes dopaminergic hESC differentiation
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www.frontiersin.orgCleaved caspase-8 also induces the release of cytrochrome c from the
mitochondria as part of the intrinsic cell death pathway, mediated by
proapoptoticproteinssuchasBAX(RiedlandShi,2004).Boththeextrinsic
and intrinsic pathways result in the activation of caspase-3, which then
catalyzes the proteolysis of many proteins leading to the cell death (Riedl
and Shi, 2004). In cultures untreated with FGF-20, we saw a signiﬁcant
number of hESC-derived cells positive for cleaved caspase-8 (Figure 4A)
and BAX (Figure 4B). In contrast, we identiﬁed almost no cells double
Figure 1.Neuronal differentiation of hESCs through theSDIA method. (A)Human embryonic stemcells (hESCs) growing on human foreskin ﬁbroblasts (hFFs).
(B) Differentiated hESCs on PA6 cells. (C–F) Expression of the early neuronal marker Nestin by the hESC-derived cells, identiﬁed by the expression of HNuc, after
differentiation for 3 weeks on PA6 cells. Detection of ﬁbroblast growth factor receptor (FGFR)-1 in: (G–I) hESCs identiﬁed by the expression of the proliferation
markerKi67;(J–L)amonolayerofPA6cells;and(M–O)hESC-derivedTH-expressingneurons.Distancebars:A–E,G,H:200mm;F:100mm;I,M–O:20mm;J–L:
50mm.
Correia et al.
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(Figure 4E) in cultures treated with FGF-20. This indicates that FGF-
20 inhibits apoptotic cell death that is mediated both via the intrinsic and
the extrinsic pathways. Addition of FGF-20 resulted in reduction in the
fraction of cells stained positive for cleaved caspase-3 (1.2 0.5%)
compared with cultures not supplemented with FGF-20 (2.5 0.2%,
Figures 4C, 4F, and 4I). Previous studies have suggested that dying cells
might downregulate the TH expression, limiting the possibility to identify
dying TH-positive neurons (Burke, 2004). It might be for this reason that
wedidnotﬁndcellsco-expressingTHandcleavedcaspase-3(Figures4G
and 4H). However, we believe that the reduction in cell death results from
ahighersurvivalofdopaminergicneuronsintheculturesduetotheknown
preferential trophic activity of FGF-20 on these neurons (Murase and
McKay, 2006; Ohmachi et al., 2000; Ohmachi et al., 2003).
Furthermore, we evaluated the effect of FGF-20 on cell proliferation.
We identiﬁed proliferating cells by the expression of Ki67 (Figures 5A
and 5B). Cultures untreated with FGF-20 contained 7 2% of Ki67-
positive cells, among the HNuc-positive cells (Figure 5C). Similarly, those
supplemented with FGF-20, Ki67-positive cells constituted 8 1% of the
total number of cells (Figure 5C). These data suggest that FGF-20 has no
effect on cell proliferation in this culture paradigm.
DISCUSSION
Midbrain dopaminergic neurons can be generated from hESCs in vitro
using several different culture protocols (Ben-Hur et al., 2004; Iacovitti
et al., 2007; Park et al., 2004; Park et al., 2005; Perrier et al., 2004; Roy
et al., 2006; Schulz et al., 2004; Yan et al., 2005; Zeng et al., 2004). We
show for the ﬁrst time that FGF-20 can be used to increase ﬁvefold the
yield of TH-expressing neurons derived from hESCs (Figures 2A–2C),
probably by promoting their differentiation and decreasing apoptotic cell
death. Speciﬁcally, FGF-20 treatment reduced the fraction of cells that
were immunoreactive for activated caspase-3, cleaved caspase-8, and
BAX(Figures 4A–4F).Thepercentage ofcleaved caspase-3-positive cells
Figure 2. Effect of FGF-20 on dopaminergic differentiation. (A,B) Representative images of TH- and HNuc-positive cells in 3 weeks differentiated hESCs/PA6
co-cultures untreated (A) and treated (B) with FGF-20 ( FGF-20 and þFGF-20, respectively). (C) Graphic representation of the percentages of TH-positive cells
among HNuc-positive cells in 3 weeks differentiated hESCs/PA6 co-cultures FGF-20 and þFGF-20. Average SEM. Student’s t-test, p-value: **¼0.0012.
(D,E) Co-expression of TH and the vesicular monoamine transporter (VMAT) 2. (F,G) Co-expression of TH and the paired-like homeodomain transcription factor 3
(PITX3). (H) RT-PCR analysis of gene expression on undifferentiated hESCs (undiff hESC line); PA6 mouse stromal cells (PA6 line); 3 weeks differentiated hESCs/
PA6 co-cultures without FGF-20 ( FGF-20 lines) and with FGF-20 (þFGF-20 lines). Undiff hESCs, undifferentiated human embryonic stem cells;  RT, no
polymerase negative control. The three lines falling into both  FGF-20 and þFGF-20 conditions represent the RT-PCR analysis of three separate cultures
maintained in the condition indicated. (I) Estimation of the TH-positive neurites length by the number of intersections of the neurites with probe lines in 3 weeks
differentiated hESCs/PA6 co-cultures  FGF-20 and þFGF-20. Average SD. (J) Soma area of TH-positive neurons in 3 weeks differentiated hESCs/PA6 co-
cultures  FGF-20 and þFGF-20. Average SD. Distance bars: A, B: 200mm; D–G: 50mm.
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www.frontiersin.orgFigure 3. Effect of FGF-20 on neuronal differentiation. (A,B) Representative images of b-III-Tubulin- and HNuc-positive cells in 3 weeks differentiated hESCs/
PA6co-cultures FGF-20(A)andþFGF-20(B).(C)Graphicrepresentationofthepercentagesofb-III-Tubulin-positivecellsamongHNuc-positivecellsin3weeks
differentiated hESCs/PA6 co-cultures  FGF-20 and þFGF-20. Average SEM. (D,E) Co-localization of b-III-Tubulin and TH in 3 weeks differentiated hESCs/PA6
co-cultures  FGF-20 (D) and þFGF-20 (E). Distance bars: A, B, D, E: 100mm.
Figure4.EffectFGF-20oncelldeath.Representativeimagesof3weeksdifferentiatedhESCs/PA6co-culturesuntreatedandtreatedwithFGF-20( FGF-20and
þFGF-20, respectively) double-stained for (A,D) HNuc and cleaved caspase-8 (B,E), HNuc and BAX (C,F) HNuc and cleaved caspase-3 (arrowheads point on
apoptoticcells),and(G,H)THandcleavedcaspase-3.(I)Graphicrepresentationofthepercentagesofcleavedcaspase-3-positivecellsamongHNuc-positivecells
in 3 weeks differentiated hESCs/PA6 co-cultures  FGF-20 and þFGF-20. Average SEM. Student’s t-test, p-value: *¼0.05. (G, H) Images showing cells
positive for cleaved caspase-3 and TH in 3 weeks differentiated hESCs/PA6 co-cultures þFGF-20. Distance bars: A, B, D, E: 50mm; C, F: 100mm; G: 200mm; H:
10mm.
Correia et al.
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Cultures expressed the midbrain dopaminergic markers, PITX3, En1, TH,
Msx1, and Aldh1 (Figures 2D–2H), supporting the notion that hESC-
derived cells were committed to a midbrain dopaminergic phenotype. The
percentageofb-III-Tubulin-positivecellsinthehESC-derivedcultureswas
about 17% regardless of whether FGF-20 was present or not (Figure 3),
indicating that this growth factor did not increase overall neuronal
differentiation.
FGF-20enhancesthedopaminergicdifferentiationofstemcellsinvitro
(Grothe et al., 2004; Takagi et al., 2005). Thus, higher yields of
dopaminergic neurons were obtained when neuronal stem cells
overexpressing Nurr1 (Grothe et al., 2004) or monkey ESCs (Takagi
et al., 2005) were differentiated in the presence of FGF-20. In
concordance to our results, the latter study showed that a combination
of bFGF and FGF-20 supported a ﬁvefold increase, from 5% to 24%, in the
percentage of TH-positive neurons (expressed as a proportion of Tuj1-
positive cells) compared to the condition when both factors were absent
(Takagi et al., 2005). The mechanism by which the combination of bFGF
and FGF-20 enhances the yield of stem cell-derived dopaminergic
neurons still remains to be investigated (Takagi et al., 2005).
Other signaling molecules, suchas sonic hedgehog (SHH), FGF-8 (Park
et al., 2005), and GDNF (Buytaert-Hoefen et al., 2004), can also increase
the number of TH-positive cells derived from hESCs that are co-cultured
withPA6cells. A combinationof SHH andFGF-8 increasedthe percentage
of TH-expressing neurons out of the TuJ1-positive cells from 26% to 41%
(Park et al., 2005). GDNF doubled the number of TH-positive cells. The
numbers of TH-positive cells per well in this study were about 934 when
GDNF was added and 443 when this neurotrophic factor was not added
(Buytaert-Hoefen et al., 2004).
Several neurotrophic factors demonstrate a growth-stimulating effect
and increase both the cell body size and the length and branching of
neurites of mesencephalic dopaminergic neurons. Those include GDNF
(Widmer et al., 2000), BDNF, NT-3, NT-4/5, nerve growth factor (NGF)
(Studer et al., 1995; Studer et al., 1996), and TGF-alpha (Alexi and Hefti,
1993). Unlike those factors, FGF-20 neither increased the cell body
size nor the length of the neurites of the TH-immunoreactive neurons
(Figures 2I and 2J). Instead the effect was limited to enhancing the
number of TH-positive neurons.
The neurotrophic activity of FGF-20 on rat mesencephalic dopami-
nergic neurons is probably mediated by FGFR-1c (Ohmachi et al., 2003).
This receptor mediates the signaling of several different FGF molecules,
such as FGF-1, -2, -3, -4, -5, -6, and -10 (Eswarakumar et al., 2005).
Consequently, it is present on many different cell types. We detected
FGFR-1 on PA6 cells, undifferentiated hESCs and hESCs-derived TH-
positiveneurons(Figures1G–1O),indicatingthattheFGF-20mightacton
different cell types in our culture paradigm. Thus, FGF-20 could act
directly on the pluripotent hESCs, promoting their differentiation into
dopaminergic neurons; on the hESC-derived dopaminergic neurons to
increase their survival; and/or indirectly, by acting on the PA6 cells and
inducing to produce factors that promote differentiation and survival of
dopaminergic neurons. FGF-20 has previously been suggested to have an
indirect mode of action on dopaminergic differentiation (Grothe et al.,
2004).
FGF-20 has been suggested to activate anti-apoptotic defenses in
cultured rat mesencephalic dopaminergic neurons (Murase and McKay,
2006). FGF-20 prevents dopaminergic neurons from dying in cultures
lacking serum, or exposed to glutamate- or 6-hydroxydopamine (6-
OHDA)-induced excitotoxicity, as well as from oxidative stress caused by
intracellular dopamine (Murase and McKay, 2006; Ohmachi et al., 2000;
Ohmachi et al., 2003). This effect was speciﬁc to calbindin-negative
cultured dopaminergic neurons, suggesting that it is limited to the A9
substantia nigra dopaminergic neurons and not evident in those derived
from the adjacent A10 ventral tegmental area (Murase and McKay, 2006).
We observed a signiﬁcant difference in the number of cells positive for
cleaved caspase-3 in FGF-20-supplemented cultures (1.2%), compared
to the untreated cultures (2.5%, Figures 4C, 4F, and 4I). Furthermore, we
also observed lower numbers of cells positive for the apoptotic markers
cleaved caspase-8 and BAX when FGF-20 was added to the cultures
(Figures 4A, 4B, 4D, and 4E). Cleaved caspase-8 is involved in initiating
the extrinsic pathway, while BAX polymerization mediates mitochondrial
cytochrome c release as an early step in the intrinsic pathway (Riedl and
Shi, 2004). Therefore, the decreased number of cells positive for cleaved
caspase-8 and BAX in FGF-20 supplemented cultures suggests that this
growth factor inhibits apoptosis through both extrinsic and intrinsic
pathways. Previously, was shown that FGF-20 treatment results in the
phosphorylation phosphoinositide-3 kinase (PI3K) (Murase and McKay,
2006). Phosphorylated PI3K then activates the Akt-dependent anti-
apoptotic pathway, which involves the inactivation of the proapoptotic
protein BAD and consequently the repression of the intrinsic pathway (del
Pesoetal.,1997).WearenotawareofanyreportedlinkbetweentheFGF-
20 signaling and the caspase-8 activation.
Although the percentage of cells exhibiting cleaved caspase-3 at the
time of ﬁxation, 21 days after starting the co-culture, was small, it has to
be emphasized that detection of cleaved caspase-3 is limited to a number
of hours before a cell eventually lyses and disappears from the culture.
These percentages of cleaved caspase-3-positive cells only indicate that
at the time point when we studied cell death, the fraction of cells
expressing cleaved caspase-3 was 2.5% in control cultures, while in FGF-
20 treated cultures only 1.2% of the cells presented cleaved caspase-3.
Thus, these percentages do not reﬂect the cells that had died throughout
the full culture experiment, which lasted for 21 days. If the rate of cell
death is similar over the full 21-day culture period, the addition of FGF-20
results in a 52% reduction in the cell death (difference between the percen-
tage of cleaved caspase-3 without and with FGF-20 (2.5 1.2¼1.3)
divided by the percentage without FGF-20 (1.3/2.5¼52)). This can
amount to a substantial increase in living TH-positive neurons in the FGF-
Figure 5. Effect FGF-20 on cell proliferation. (A,B) Representative images of Ki67- and HNuc-positive cells in 3 weeks differentiated hESCs/PA6 co-cultures –
FGF-20 (A) and þFGF-20 (B). Arrowheads point on cells going through mitosis. (C) Graphic representation of the percentages of Ki67-positive cells among HNuc-
positive cells in 3 weeks differentiated hESCs/PA6 co-cultures  FGF-20 and þFGF-20. Average SEM. Distance bars: 100mm.
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FGF-20 are probably dopaminergic neurons, assuming that FGF-20
preferentially affects this type of neurons as reported previously (Ohmachi
et al., 2000; Ohmachi et al., 2003). Expression of this growth factor is
speciﬁc to the substantia nigra pars compacta in the rat brain (Ohmachi
et al., 2000). In addition, the receptor for FGF-20, FGFR1c, is highly
expressed by TH-positive neurons in the substantia nigra and is lower in
other brain regions (Ohmachi et al., 2003). Moreover, in primary, serum-
free, rat mesencephalic cultures, FGF-20 only rescues the TH-expressing
cells and does not affect the total number of neurons (Ohmachi et al.,
2003). Unfortunately, we were not able to deﬁnitively determine if the
dying neurons were dopaminergic. The identiﬁcation of dying
dopaminergic neurons in culture cannot be easily done, because dying
cells downregulate cytosolic proteins such as TH (Burke, 2004).
Therefore, the fact that we did not ﬁnd cells immunopositive for both
TH and cleaved caspase-3, does not clarify the issue.
In conclusion, in the present study we demonstrate that FGF-20 has
potent effect on dopaminergic neurons generated from hESCs. This effect
couldlargely be duetospeciﬁcpromotion ofcelldifferentiation toward the
dopaminergic phenotype combined with a reduced cell death. The high
yield ofdopaminergic neuronsfrom hESCs might provide an advantage for
neuraltransplantationinmodelsofParkinson’sdisease.Forthisreason,in
our future studies we are interested to see ifFGF-20 can improvethe yield
of hESC-derived TH-positive neurons after grafting. One of the major
limitations in the application of hESCs in cell therapy for Parkinson’s
disease is that only few hESC-derived dopaminergic neurons survive after
transplantation into animal models (Ben-Hur et al., 2004; Brederlau et al.,
2006; Park et al., 2005; Zeng et al., 2004). We believe that FGF-20 can
contribute to obtain large quantities of dopaminergic neurons with
substantia nigra phenotype from hESCs, increasing the chances of
success for stem cell-based therapy against Parkinson’s disease.
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